Live Breaking News & Updates on Akero therapeutics

Stay informed with the latest breaking news from Akero therapeutics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Akero therapeutics and stay connected to the pulse of your community

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Akero Therapeutics, Inc. - AKRO

NEW YORK, April 28, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Akero Therapeutics, Inc.  . Such investors are advised to contact Danielle Peyton at...

Tel-aviv , Israel , Paris , France-general- , France , Chicago , Illinois , United-states , New-york , London , City-of , United-kingdom

Akero Therapeutics (NASDAQ:AKRO) Coverage Initiated at Bank of America

Akero Therapeutics (NASDAQ:AKRO) Coverage Initiated at Bank of America
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Jonathan-young , Andrew-cheng , Akero-therapeutics-company-profile , Northern-trust-corp , Vanguard-group-inc , Securities-exchange-commission , Alkeon-capital-management , Akero-therapeutics-inc , Akero-therapeutics , Get-free-report

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Akero ...

NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Akero Therapeutics, Inc. (“Akero” or the “Company”) (NASDAQ: AKRO). Such investors are

Paris , France-general- , France , Chicago , Illinois , United-states , Tel-aviv , Israel , London , City-of , United-kingdom , New-york

Stock Analysts' New Coverage for April 22nd (AAU, AEZS, AGL, AIRG, AKRO, ATAT, AWX, BCML, BDL, BLPH)

Stock Analysts' New Coverage for April 22nd (AAU, AEZS, AGL, AIRG, AKRO, ATAT, AWX, BCML, BDL, BLPH)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada , United-states , America , Janney-montgomery-scott , Lotus-technology , Royal-bank , Rubicon-technology , Hovde-group , Deutsche-bank-aktiengesellschaft , News-ratings-for-almaden-minerals-ltd-daily , Eagle-bancorp-montana , Eastgroup-properties

Stock Analysts' New Coverage for April 22nd (AAU, AEZS, AGL, AIRG, AKRO, ATAT, AWX, BCML, BDL, BLPH)

Stock Analysts’ new coverage for Monday, April 22nd: StockNews.com initiated coverage on shares of Almaden Minerals (NYSE:AAU). The firm issued a sell rating on the stock. StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS) (TSE:AEZ). StockNews.com issued a sell rating on the stock. Citigroup Inc. started coverage on shares of agilon health (NYSE:AGL). They […]

Canada , United-states , America , Janney-montgomery-scott , America-co , Credit-suisse-group , Jaguar-health , Almaden-minerals , Wolfe-research , Alliance-bancorporation , Madrigal-pharmaceuticals , Jpmorgan-chase-co

Hepion ends Phase 2 study for NASH drug due to cash restraints (NASDAQ:HEPA)

Hepion ends Phase 2 study for NASH drug due to cash restraints (NASDAQ:HEPA)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

John-brancaccio , Sagimet-biosciences , Hepion-pharmaceuticals , Madrigal-pharmaceuticals , Human-liver-anatomy , Hepion-executive-chairman-john-brancaccio , Eli-lilly , Novo-nordisk , Viking-therapeutics , Akero-therapeutics , Galectin-therapeutics , Terns-pharma

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Akero Therapeutics, Inc. - AKRO

NEW YORK, April 20, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Akero Therapeutics, Inc.  . Such investors are advised to contact Danielle Peyton at...

Tel-aviv , Israel , New-york , United-states , Paris , France-general- , France , Chicago , Illinois , London , City-of , United-kingdom

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Akero Therapeutics, Inc.

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Akero Therapeutics, Inc. ("Akero" or the "Company") (NASDAQ: AKRO). Such...

Chicago , Illinois , United-states , New-york , Tel-aviv , Israel , London , City-of , United-kingdom , Paris , France-general- , France